FIRST EXTENSION - GRANTED
granted
on 04 Jun 2024
Last Applicant/ Owned by
131 Hartwell Avenue, Suite 320
Lexington
MA
02421
Serial Number
97711210 filed on 09th Dec 2022
Registration Number
N/A
Correspondent Address
BOSTON, MA 02109
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VITRUXTY
pharmaceuticals in the nature of an injectable solution for intravitreal use for the prevention of eye conditions including proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and retinitis pigmentosa
Classification Information
Class [005]
Pharmaceutical Products
pharmaceuticals in the nature of an injectable solution for intravitreal use for the prevention of eye conditions including proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and retinitis pigmentosa
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97711210
Mark Type
No Service/Collective Mark
Attorney Docket Number
No A2119-2007
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Jun 2024 | SOU EXTENSION 1 GRANTED |
| 04th Jun 2024 | SOU EXTENSION 1 FILED |
| 04th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 05th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 10th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 20th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 06th Sep 2023 | ASSIGNED TO EXAMINER |
| 06th Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |